In clinical use, the most commonly reported side effects are: Mild injection site redness or swelling (resolves within hours) Occasional lightheadedness following injection (less common, position-dependent) Temporary nausea with oral administration in some patients Who should not use BPC-157: Patients with active cancer or a history of cancer should discuss BPC-157 carefully with their oncologist before use angiogenic peptides theoretically could support tumor vascularity, though no evidence of this has been demonstrated in animals
The knee-jerk reaction to discontinue all of the patients medications is not appropriate and can complicate the clinical course if chronic conditions are not adequately treated
J Neurotrauma 35(17):20252035 Burda JE, Bernstein AM, Sofroniew MV (2016) Astrocyte roles in traumatic brain injury
Important Considerations and Potential Challenges Managing Digestive Comfort Introducing high-calorie protein powders can initially cause digestive discomfort, including bloating or mild stomach upset
The mean nucleation temperatures of threonine (26.2 2.7 C
PINK1/Parkin-mediated mitophagy in neurodegenerative diseases